Patent · US Expired

Methods of reducing the levels of protoporphyrin IX in recombinant hemoglobin preparations

US6136565A · kind A · utility

60Cited by
2References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 18, 1999
Grant dateOct 24, 2000
Priority date
Expiry dateOct 18, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to recombinant hemoglobin solutions containing reduced amounts of protoporphyrin IX and to methods of producing such hemoglobin solutions. The methods are accomplished by overexpressing the hemH gene in a suitable host cell or by increasing the production of hemH in a host cell, for example, by integration of the hemH gene into the chromosome of the host cell or by inserting multiple copies of the gene in host cells naturally having a hemH gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.